RecallDepth
Class III Terminated

Depo-Medrol (methylprednisolone acetate injectable suspension USP), 40 mg/ mL, 1 mL Single-Dose Vial, Rx only, Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, New York NY 10017 NDC 0009-3073-03 DEPO-MEDROL methylprednisolone acetate Injectable Suspension USP, 40 mg per mL, 1 mL Single-Dose Vial, Rx ONLY, Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, New York NY 10017, NOVAPLUS is a registered trademark of Novation, LLC NDC 0009-3073-23

This recall has been terminated (originally issued August 20, 2014).

Company
Pfizer Inc.
Recall Initiated
July 30, 2014
Posted
August 20, 2014
Recall Number
D-1537-2014
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
93,800 vials
Firm Location
New York, NY, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed pH Specification: A pH result of 2.9 was obtained at the 9 month stability test interval at 25C/60%RH. The registered specification for pH is 3.0 - 7.0

Distribution

Nationwide

Lot / Code Info

Lot H43272, H43265 Exp. 09/14

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class III Drug recalls